Adaptive Biotechnologies (ADPT) Stock Highlights

6.39 | +6.5%

2024-12-21 04:46:38

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Statistics

Range Today

5.84 6.51

Volume Today 1.57M

Range 1 Year

2.28 7.07

Volume 1 Year 356.84M

Range 3 Year

2.28 30.51

Volume 3 Year 979.32M

Range 10 Year

2.28 71.25

Volume 10 Year 1.54B

Highlights

Market Capitalization 858.91M (small)

Floating Shares 76.75M

Current Price 6.39

Price To Earnings -3.95

Price To Revenue 4.74

Price To Book 3.84

Earnings Per Share -1.52

Payout Ratio 0%

Performance

Latest +6.5%

1 Month +44.57%

3 Months +35.38%

6 Months +109.51%

1 Year +25.79%

3 Years -77.58%

5 Years -78.9%

10 Years -83.62%

Benchmarks

Market Capitalization

159 / 368

Gross Profits

164 / 278

Total Revenue

63 / 300

Total Rank

32 / 368

Free Cashflow

257 / 352

Performance 5 years

225 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.